| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Anatomy and Histology, Centre for Neuroscience, Flinders University, Adelaide SA 5001, Australia
The role of the soluble NSF attachment protein receptor (SNARE) protein complex in release of multiple cotransmitters from autonomic vasodilator neurons was examined in isolated segments of guinea pig uterine arteries treated with botulinum neurotoxin A (BoNTA; 50 nM). Western blotting of protein extracts from uterine arteries demonstrated partial cleavage of synaptosomal-associated protein of 25 kDa (SNAP-25) to a NH2-terminal fragment of ~24 kDa by BoNTA. BoNTA reduced the amplitude (by 70-80%) of isometric contractions of arteries in response to repeated electrical stimulation of sympathetic axons at 1 or 10 Hz. The amplitude of neurogenic relaxations mediated by neuronal nitric oxide (NO) was not affected by BoNTA, whereas the duration of peptide-mediated neurogenic relaxations to stimulation at 10 Hz was reduced (67% reduction in integrated responses). In contrast, presynaptic cholinergic inhibition of neurogenic relaxations was abolished by BoNTA. These results demonstrate that the SNARE complex has differential involvement in release of cotransmitters from the same autonomic neurons: NO release is not dependant on synaptic vesicle exocytosis, acetylcholine release from small vesicles is highly dependant on the SNARE complex, and neuropeptide release from large vesicles involves SNARE proteins that may interact differently with regulatory factors such as calcium.
pelvic neurons; neuropeptides; nitric oxide; acetylcholine; synaptosomal-associated protein of 25 kDa
This article has been cited by other articles:
|
|
 |
|
  D. L. Kellogg Jr, J. L. Zhao, and Y. Wu Neuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo J. Physiol., February 1, 2008; 586(3): 847 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Smyth, L. T. Breen, and V. N. Mutafova-Yambolieva Nicotinamide adenine dinucleotide is released from sympathetic nerve terminals via a botulinum neurotoxin A-mediated mechanism in canine mesenteric artery Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1818 - H1825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ansiaux, C. Baudelet, G. O. Cron, J. Segers, C. Dessy, P. Martinive, J. De Wever, J. Verrax, V. Wauthier, N. Beghein, et al. Botulinum Toxin Potentiates Cancer Radiotherapy and Chemotherapy Clin. Cancer Res., February 15, 2006; 12(4): 1276 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Piovesan, H. G. Teive, P. A. Kowacs, M. V. D. Coletta, L. C. Werneck, and S. D. Silberstein An open study of botulinum-A toxin treatment of trigeminal neuralgia Neurology, October 25, 2005; 65(8): 1306 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Voller, T. Sycha, B. Gustorff, L. Schmetterer, S. Lehr, H. G. Eichler, E. Auff, and P. Schnider A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A Neurology, October 14, 2003; 61(7): 940 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. James, J. P. Ryan, and H. P. Parkman Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G291 - G297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Morris, P. Jobling, and I. L. Gibbins Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2627 - H2635. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
